Chee-Yin Chai Selected Research

Chee-Yin Chai Research Topics

Disease

98	Neoplasms (Cancer) 01/2021 - 01/2002
33	Carcinogenesis 07/2019 - 09/2004
19	Carcinoma (Carcinomatosis) 01/2017 - 08/2003
14	Inflammation (Inflammations) 06/2022 - 02/2007
13	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2004
10	Rectal Neoplasms (Rectal Cancer) 10/2021 - 05/2012
10	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 05/2007
10	Hepatocellular Carcinoma (Hepatoma) 12/2018 - 06/2007
9	Breast Neoplasms (Breast Cancer) 09/2018 - 05/2011
8	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 12/2013
8	Pulmonary Hypertension 01/2021 - 03/2004
8	Burns 01/2020 - 01/2015
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 04/2007
6	Vascular Remodeling 01/2021 - 11/2004
5	Bowen's Disease (Disease, Bowen) 11/2018 - 09/2004
5	Adenocarcinoma 05/2017 - 01/2006
5	Hypoxia (Hypoxemia) 07/2016 - 08/2008
4	Cholesteatoma 07/2022 - 10/2003
4	Left Ventricular Dysfunction 01/2020 - 06/2006
4	Fibrosis (Cirrhosis) 01/2020 - 03/2005
4	Neuralgia (Stump Neuralgia) 04/2019 - 01/2014
4	Stomach Neoplasms (Stomach Cancer) 10/2017 - 08/2003
4	Adenoma (Adenomas) 09/2015 - 11/2005
3	Middle Ear Cholesteatoma 07/2022 - 10/2003
3	Hyperglycemia 06/2022 - 05/2017
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 06/2022 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2016
3	Atrophy 01/2020 - 01/2015
3	Hyperalgesia 04/2019 - 01/2014
3	Skin Neoplasms (Skin Cancer) 11/2018 - 09/2004
3	Aneuploidy (Aneuploid) 02/2018 - 09/2006
3	Triple Negative Breast Neoplasms 01/2018 - 02/2016
3	Brain Neoplasms (Brain Tumor) 04/2017 - 05/2012
3	Body Weight (Weight, Body) 08/2016 - 01/2007
3	Right Ventricular Hypertrophy 05/2015 - 06/2010
3	Lung Neoplasms (Lung Cancer) 11/2014 - 07/2011
3	Nasal Polyps (Nasal Polyp) 01/2013 - 08/2008
3	Adenocarcinoma of Lung 05/2012 - 01/2006
3	Infections 01/2011 - 01/2007
3	Verrucous Carcinoma 05/2010 - 06/2003

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2002
15	ArsenicIBA 11/2018 - 09/2004
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2012
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 04/2005
9	Indicators and Reagents (Reagents)IBA 01/2022 - 09/2005
7	salicylhydroxamic acid (SHAM)IBA 01/2020 - 03/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 04/2007
6	Messenger RNA (mRNA)IBA 06/2016 - 01/2002
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2013 - 11/2007
5	Phosphotransferases (Kinase)IBA 12/2021 - 09/2015
5	CytokinesIBA 01/2021 - 08/2008
5	Small Interfering RNA (siRNA)IBA 07/2019 - 01/2012
5	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017 - 03/2004
5	KMUP 1IBA 08/2016 - 05/2009
5	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2016 - 09/2005
5	arseniteIBA 12/2015 - 11/2007
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2014
4	Cadherins (E-Cadherin)IBA 01/2020 - 01/2017
4	Cyclin D1IBA 07/2019 - 04/2008
4	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2018 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 02/2018 - 05/2005
4	Biological ProductsIBA 10/2017 - 06/2005
4	rho-Associated KinasesIBA 01/2017 - 06/2010
4	Matrix Metalloproteinases (MMPs)IBA 08/2016 - 01/2011
4	Hormones (Hormone)IBA 01/2016 - 01/2012
4	ParaffinIBA 08/2007 - 08/2003
3	CalreticulinIBA 07/2022 - 05/2005
3	IntegrinsIBA 12/2021 - 09/2013
3	AntigensIBA 01/2021 - 08/2003
3	Caspase 3 (Caspase-3)IBA 11/2020 - 07/2019
3	CaspasesIBA 11/2020 - 01/2019
3	Lysine (L-Lysine)FDA Link 01/2020 - 10/2017
3	Beclin-1IBA 12/2019 - 12/2013
3	Carrier Proteins (Binding Protein)IBA 11/2018 - 06/2016
3	Pharmaceutical PreparationsIBA 10/2017 - 06/2003
3	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 11/2014
3	EnzymesIBA 01/2017 - 05/2009
3	CateninsIBA 01/2017 - 01/2013
3	Endothelin-1 (Endothelin 1)IBA 01/2017 - 03/2004
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2016 - 01/2012
3	Glucose (Dextrose)FDA LinkGeneric 08/2016 - 01/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2016 - 09/2006
3	ErbB Receptors (EGF Receptor)IBA 04/2016 - 10/2003
3	AntioxidantsIBA 10/2013 - 05/2011
3	Drinking WaterIBA 07/2013 - 09/2006
3	Caveolin 1IBA 10/2012 - 07/2007
3	phthalic acid (phthalate)IBA 08/2012 - 01/2012
3	butylbenzyl phthalate (benzyl butyl phthalate)IBA 08/2012 - 01/2012
3	Methotrexate (Mexate)FDA LinkGeneric 05/2010 - 06/2003
3	AntibodiesIBA 03/2009 - 01/2006
3	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2008 - 01/2005
3	Monoclonal AntibodiesIBA 08/2007 - 08/2003
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2006 - 04/2005
3	Biotin (Vitamin H)FDA Link 01/2004 - 08/2003

Therapy/Procedure

20	Therapeutics 01/2021 - 05/2005
11	Chemoradiotherapy 10/2021 - 05/2012
9	Radiotherapy 01/2021 - 09/2007
9	Drug Therapy (Chemotherapy) 04/2017 - 06/2003
4	Adjuvant Chemotherapy 11/2014 - 06/2005
3	Transplantation 12/2017 - 01/2013